Lunai Bioworks Inc (LNAI) Return on Equity ROE from the third quarter 2026 to third quarter 2025 and annually, average high and low, overall ranking from Mar 31 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Lunai Bioworks Inc   (NASDAQ: LNAI)

Lunai Bioworks Inc 's ROE per quarter

Return on Equity, Quarterly Results, Trends, Rankings, Statistics


What is ROE for Lunai Bioworks Inc in the third quarter 2026?
Due to the lack of equity, it was not possible to calculate Lunai Bioworks Inc 's return on equity (ROE) in its third quarter 2026

What is ROE?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Equity (Mar 31 2026)
III. Quarter		 (Dec 31 2025)
II. Quarter		 (Sep 30 2025)
I. Quarter		 (Jun 30 2025)
IV. Quarter		 (Mar 31 2025)
III. Quarter
Y / Y Equity Change - - - - -
Y / Y Net Income Change - - - - -
Net Income (TTM) in Millions -128 -126 -131 -178 -67
Return On Equity (TTM) - -1241.35 % -385.07 % -288.06 % -66.92 %
LNAI's Total Ranking # # # # #
Equity (TTM) in Millions -10 -14 -13 -21 88
Seq. Equity Change - - - - 7.71 %
Seq. Net Income Change - - - - -

Back to LNAI Management Effectiveness >> LNAI's 5 Years Annual ROE >> Compare LNAI ROE to its Competitors
Return On Equity Company Ranking
Within: No.
Industry #
Sector #
Overall #

Return On Equity Statistics
High Average Low
0 %
0 %
0 %
 





LNAI Annual Return On Equity (Jun 30 2025)
2025		 (Jun 30 2024)
2024		 (Jun 30 2023)
2023		 (Jun 30 2022)
2022		 (Jun 30 2021)
2021
Total Equity in Millions -21 132 47 73 175
Y / Y Equity Change - 183.81 % -35.96 % -58.42 % 5.05 %
Net Income in Millions -178 -88 -40 -113 -27
Y / Y Net Income Change - - - - -
Return On Equity - -67 % -85.34 % -156.2 % -15.3 %

Back to LNAI Management Effectiveness >> LNAI's 5 Years Annual ROE >> Compare LNAI ROE to its Competitors




More Return On Equity Ratios
Major Pharmaceutical Preparations Industry Roe Trends and Statistics
Healthcare Sector Return On Equity Statistics
LNAI's' Return on Equity at Yahoo Finance
LNAI's Roe Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Equity
Lowest Ranking Return On Equity
Subscribers only: Roe for LNAI's Competitors
Subscribers only: Roe for Lunai Bioworks Inc 's Suppliers
Subscribers only: Return On Equity for LNAI's Customers




Companies with similar Return On Equity at Mar 31 2026, within Healthcare Sector ROE
Xeris Biopharma Holdings Inc   791.74 %
Glucotrack Inc   581.98 %
Silexion Therapeutics Corp  516.87 %
Aveanna Healthcare Holdings Inc   242.29 %
Q32 Bio Inc   230.68 %
Emmis Acquisition Corp   224.85 %
Interpace Biosciences Inc   215.31 %
Coherus Oncology inc   214.57 %
Oncotelic Therapeutics Inc   183.27 %

Date modified: 2026-09-26T07:27:16+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.